Lam Krystal Tsz Ting, Hung Alex Tsz Wai, Lau Kendy, Lee Eric Kam Pui
Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Li Ping Medical Library, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
J Neurodev Disord. 2024 Dec 19;16(1):68. doi: 10.1186/s11689-024-09584-3.
BACKGROUND & AIMS: Effective treatment for anterior drooling in children with neurological disorders can lead to improved social interactions, reduced physical complications such as perioral infections, and enhanced quality of life for both patients and their parents. Elastic therapeutic taping (ETT) has emerged a novel intervention for drooling, but its evidence was limited. This study systematically reviewed the effectiveness of ETT on reducing anterior drooling in children with neurological disorders.
Multiple electronic databases, such as Ovid MEDLINE, Embase, and Cochrane Library were searched from inception till 30th October 2024. Randomized controlled trials (RCTs) were included if they: (a) used ETT as a treatment for drooling or swallowing difficulties; (b) included participants aged < 18 years old; (c) included participants with anterior drooling and neurological disorders; (d) compared effects of ETT alone or combined with other treatments (e.g. oral motor therapy (OMT)) with no taping, sham taping or other treatments, and (e) published in English. The Cochrane Risk-of-Bias tool was used to assess risk of bias for the included studies.
Seven parallel-arm RCTs, which were conducted in South/southwest Asia, Africa, South America and Middle East, were included. In total, 220 children aged 1 to 11 were included, of which 97 received solely ETT in 4 studies, while 24 received ETT plus OMT in 2 studies. ETT combined with OMT was more effective in reducing drooling in the included 2 RCTs, though the results of ETT alone were inconsistent, likely due to heterogeneity observed in control conditions, application methods, and outcome measures. No side effects were reported in all studies.
This review suggests that ETT combined with OMT is effective in reducing drooling in children with neurological disorders, with no evidence of side effects.
(PROSPERO no.: CRD42023488664).
有效治疗神经功能障碍儿童的流涎问题，可改善社交互动，减少口周感染等身体并发症，并提高患者及其父母的生活质量。弹性治疗贴布（ETT）已成为一种治疗流涎的新型干预措施，但其证据有限。本研究系统评价了ETT对减少神经功能障碍儿童流涎的有效性。
检索多个电子数据库，如Ovid MEDLINE、Embase和Cochrane图书馆，检索时间从建库至2024年10月30日。纳入的随机对照试验（RCT）需满足以下条件：（a）使用ETT治疗流涎或吞咽困难；（b）纳入年龄小于18岁的参与者；（c）纳入有流涎和神经功能障碍的参与者；（d）比较单独使用ETT或与其他治疗（如口腔运动疗法（OMT））联合使用与不使用贴布、假贴布或其他治疗的效果；（e）以英文发表。使用Cochrane偏倚风险工具评估纳入研究的偏倚风险。
纳入了7项平行组RCT，这些研究在南亚/西南亚、非洲、南美洲和中东地区开展。总共纳入了220名1至11岁的儿童，其中97名在4项研究中仅接受ETT治疗，而24名在2项研究中接受ETT加OMT治疗。在纳入的2项RCT中，ETT联合OMT在减少流涎方面更有效，尽管单独使用ETT的结果不一致，这可能是由于在对照条件、应用方法和结局测量中观察到的异质性。所有研究均未报告副作用。
本综述表明，ETT联合OMT可有效减少神经功能障碍儿童的流涎，且无副作用证据。
（PROSPERO编号：CRD42023488664）
